glp 1 efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis GLP-1 Medications for Weight Loss:

Available at: 99 KaryekarC.DonovanM.AllenE.FlemingD.RavichandranS.ChenR

Speak with your doctor Kumar says patients should ask their physicians about what they see as the long-term plan for their weight-loss program and the continued role of medication in that, and consider the balance of medication versus lifestyle intervention as you progress through life

Additionally, severe gastrointestinal side effects can occasionally lead to dehydration and electrolyte imbalances, which may indirectly affect cardiac function

Xue X, Ren Z, Zhang A, Yang Q, Zhang W, Liu F (2016) Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials